Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors

• Hoofdauteurs: Francesca Barei (Auteur), Paolo Calzari (Auteur), Luca Valtellini (Auteur), Alessandra Chiei Gallo (Auteur), Gabriele Perego (Auteur), Simona Tavecchio (Auteur), Martina Zussino (Auteur), Angelo V. Marzano (Auteur), Silvia Ferrucci (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background Atopic dermatitis (AD) profoundly impacts patients' lives, necessitating long-term systemic treatments.Methods This retrospective study involved 709 severe AD patients receiving dupilumab. Drug survival (DS) was analyzed using Kaplan-Meier curves, evaluating reasons for discontinuati...